Cyclooxygenase-2 expression in cervical intraepithelial neoplasia

Annals of the New York Academy of Sciences

Volumn 1171, Issue , 2009, Pages 111-115

  Kim, Kidong ^a   Jeon, Yong Tark ^b   Park, In Ae ^b   Kim, Jae Weon ^b   Park, Noh Hyun ^b   Kang, Soon Beom ^b   Lee, Hyo Pyo ^b   Song, Yong Sang ^b  

^a Korea Institute of Radiation and Medical Science   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Age factors; Cervical intraepithelial neoplasia (CIN); Cyclooxygenase 2; Epithelium; Menopause; Stromal cells

Indexed keywords

ANTIBODY; CYCLOOXYGENASE 2; PARAFFIN;

ADULT; CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POSTMENOPAUSE; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM;

EID: 69149088521     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04724.x     Document Type: Conference Paper

References (25)

1. Dai, Y. et al. 2005. The expression of cyclooxygenase-2, VEGF and PGs in CIN and cervical carcinoma. Gynecol. Oncol. 97 : 96 103.
2. Dursun, P. et al. 2007. Cyclooxygenase-2 expression in cervical intraepithelial neoplasia III and squamous cell cervical carcinoma, and its correlation with clinicopathologic variables. Int. J. Gynecol. Cancer 17 : 164 173.
3. Kim, M.H. et al. 2003. Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes. Gynecol. Oncol. 90 : 83 90.
4. Seo, S.S. et al. 2004. Expression of cyclooxygenase-2 in association with clinicopathological prognostic factors and molecular markers in epithelial ovarian cancer. Gynecol. Oncol. 92 : 927 935.
5. Kang, S. et al. 2006. Elevation of cyclooxygenase-2 is related to lymph node metastasis in adenocarcinoma of uterine cervix. Cancer Lett. 237 : 305 311.
6. Surh, Y.J. et al. 2001. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res. 480-481 : 243 268.
7. Williams, C., R.L. Shattuck-Brandt R.N. DuBois. 1999. The role of COX-2 in intestinal cancer. Ann. N. Y. Acad. Sci. 889 : 72 83.
8. Williams, C.S., M. Mann R.N. DuBois. 1999. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18 : 7908 7916.
9. Kawada, M. et al. 2003. Cyclooxygenase-2 expression and angiogenesis in gastric hyperplastic polyp-association with polyp size. Digestion 67 : 20 24.
10. Sheehan, K.M. et al. 2004. The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas. Eur. J. Gastroenterol. Hepatol. 16 : 619 625.
11. Prescott, S.M. 2000. Is cyclooxygenase-2 the alpha and the omega in cancer? J. Clin. Invest. 105 : 1511 1513.
12. Farley, J. et al. 2004. Cyclooxygenase-2 expression predicts recurrence of cervical dysplasia following loop electrosurgical excision procedure. Gynecol. Oncol. 92 : 596 602.
13. Kim, J.Y. et al. 2005. Cyclooxygenase-2 and c-erbB-2 expression in uterine cervical neoplasm assessed using tissue microarrays. Gynecol. Oncol. 97 : 337 341.
14. Ferrandina, G. et al. 2002. Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications. Br. J. Cancer 87 : 1145 1152.
15. Oshima, M. et al. 1996. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87 : 803 809.
16. Williams, C.S. et al. 2000. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Invest. 105 : 1589 1594.
17. Munger, K. et al. 1992. Interactions of HPV E6 and E7 oncoproteins with tumour suppressor gene products. Cancer Surv. 12 : 197 217.
18. Kinzler, K.W. B. Vogelstein. 1998. Landscaping the cancer terrain. Science 280 : 1036 1037.
19. Subbaramaiah, K. A.J. Dannenberg. 2007. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange. Cancer Res. 67 : 3976 3985.
20. Lee, T.S. et al. 2007. Increased cyclooxygenase-2 expression associated with inflammatory cellular infiltration in elderly patients with vulvar cancer. Ann. N. Y. Acad. Sci. 1095 : 143 153.
21. Jeon, Y.T. et al. 2004. Cyclooxygenase-2 and p53 expressions in endometrial cancer. Cancer Epidemiol. Biomarkers Prev. 13 : 1538 1542.
22. Kim, Y.B. et al. 2002. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy. Cancer 95 : 531 539.
23. Lin, H. et al. 2004. Prediction of disease persistence after conization for microinvasive cervical carcinoma and cervical intraepithelial neoplasia grade 3. Int. J. Gynecol. Cancer 14 : 311 316.
24. Tjalma, W. et al. 1999. Angiogenesis in cervical intraepithelial neoplasia and the risk of recurrence. Am. J. Obstet. Gynecol. 181 : 554 559.
25. Hardy, D.B. et al. 2006. Progesterone receptor plays a major antiinflammatory role in human myometrial cells by antagonism of nuclear factor-kappaB activation of cyclooxygenase 2 expression. Mol. Endocrinol. 20 : 2724 2733.